Use of a Hypercaloric and Hyperprotein Supplement Enriched with Immunonutrients in Multi-pathological Malnourished Patients to Improve the Incidence and Prevalence of Pressure Sores
- Conditions
- MultimorbidityComorbidityMalnutritionPressure Ulcer Prevention
- Registration Number
- NCT06726486
- Lead Sponsor
- University of Cadiz
- Brief Summary
The goal of this study is to evaluate the efficacy of a hypercaloric, hyperproteic enteral formula enriched with immunonutrients in preventing and treating pressure injuries in hospitalized malnourished patients.
Participants will take enteral formula (a complete hyperproteic and hypercaloric oral nutritional supplement with a fibre mixture enriched in omega 3, L-arginine and nucleotides, providing vitamin C and Zinc) or a hyperproteic and hypercaloric oral nutritional supplement with fibre mixture every day for 30 days.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 69
- Hospitalized chronic patients with complex needs in the Internal Medicine Department of a regional hospital.
- Malnourished or at risk of malnutrition.
- Moderate-high risk of developing pressure-related injuries or the presence of pressure-related injuries.
- Limitations in oral intake (due to pathologies, state of health, among others).
- Contraindications for using the oral route and digestive intolerance or allergy to any of the components of the products.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Presence of pressure-related injuries 15 and 30 days Dichotomous variable: Yes/No.
Risk of developing pressure-related injuries 15 and 30 days Measurement instrument: Braden scale (low risk, moderate risk, high risk).
Categorization of pressure-related injuries 15 and 30 days Measurement instrument: PUSH scale (I, II, III, IV).
Pressure-related injuries healing 15 and 30 days Measurement instrument: PUSH scale (closed, epithelial tissue, granulation tissue, sphacelium, necrotic tissue).
Degree of dependence 0, 15, and 30 days. Measurement instruments (description): Barthel score (independent, mild, moderate, severe).
Weight loss 0, 15 and 30 days. Measurement instruments (description): Weight scale (kg).
% of dietary intake 15 and 30 days. 0%, 25%, 50%, 75%, 100% intake.
ONS adherence 15 and 30 days. 0%, 25%, 50%, 75%, 100% intake.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Punta Europa University of Cadiz
🇪🇸Algeciras, Cadiz, Spain